AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on September 3, 2026

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
Alector to Participate in Upcoming Healthcare Conferences
Concrete Pumping Holdings Reports Strong Third Quarter Fiscal Year 2026 Results and Initiates Quarterly Dividend
eGain Reports Fiscal 2026 Results: Total Revenue Up 3%, AI Customer Revenue Up 20%, Company Named a Leader in Gartner's First Customer Service Knowledge Management MQ
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Reliance Global Group Adopts One-Year Stockholder Rights Plan to Protect Stockholder Value
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arvinas to Participate in Upcoming Investor Conferences
Hooker Furnishings Declares Quarterly Dividend
Rein Therapeutics to Present at Upcoming September Investor Conferences
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
G2 Recognizes SlickText for Outstanding Customer Experience
PZZA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Papa John’s (NASDAQ: PZZA) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
TYGO Investor News: If You Have Suffered Losses in Tigo Energy, Inc. (NASDAQ: TYGO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Market Just Told You Which Layer Of AI Biology It Is Paying For

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.